Helsinn Therapeutics (U.S.), Inc. drugs

3 results

Akynzeo (netupitant and palonosetron)

(Netupitant and Palonosetron)
Helsinn Therapeutics (U.S.), Inc.
Usage: AKYNZEO is indicated, in combination with dexamethasone, for the prevention of acute and delayed nausea and vomiting in adults undergoing initial and repeat courses of highly emetogenic cancer chemotherapy. It combines palonosetron for acute prevention and netupitant (or fosnetupitant in injection form) for both acute and delayed prevention.

Aloxi (palonosetron hydrochloride)

(palonosetron hydrochloride)
Helsinn Therapeutics (U.S.), Inc.
Usage: ALOXI capsules are indicated for adults to prevent acute nausea and vomiting linked to initial and repeat courses of moderately emetogenic cancer chemotherapy.

Valchlor (mechlorethamine hydrochloride)

(mechlorethamine hydrochloride)
Helsinn Therapeutics (U.S.), Inc.
Usage: VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have previously undergone skin-directed therapy.